Fiscal period | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
Period End Date | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 |
Revenues | 1,122.29 | 958.43 | 991.35 | 883.11 | 762.31 | 685.99 | 628.49 | 499.28 | 478.45 | 442.93 |
Revenues (from related parties) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Total Revenues | 1,122.29 | 958.43 | 991.35 | 883.11 | 762.31 | 685.99 | 628.49 | 499.28 | 478.45 | 442.93 |
Cost of revenues | 690.93 | 623.94 | 655.49 | 584.86 | 495.14 | 447.72 | 402.92 | 332.54 | 290.94 | 271.88 |
Gross Profit | 431.36 | 334.50 | 335.86 | 298.26 | 267.17 | 238.27 | 225.58 | 166.74 | 187.51 | 171.05 |
Depreciation and amortization | 49.13 | 50.46 | 51.98 | 48.57 | 38.55 | 34.58 | 31.47 | 28.03 | 24.92 | 25.62 |
General and administrative expenses | 142.04 | 113.89 | 126.91 | 116.20 | 102.52 | 88.62 | 77.29 | 65.38 | 58.80 | 57.19 |
Selling and marketing expenses | 84.31 | 60.12 | 71.84 | 63.61 | 53.38 | 50.58 | 49.47 | 39.29 | 36.38 | 31.01 |
Impairment charges | -- | -- | (8.67) | (20.06) | -- | -- | -- | -- | -- | -- |
Total Operating Expenses | 275.48 | 224.48 | 259.40 | 248.44 | 194.44 | 173.78 | 158.23 | 132.70 | 120.09 | 113.82 |
Operating Income (loss) | 155.88 | 110.02 | 76.45 | 49.82 | 72.73 | 64.50 | 67.34 | 34.04 | 67.42 | 57.23 |
Interest expense | 7.56 | 11.19 | 13.61 | 7.23 | 1.89 | 1.34 | 1.34 | 0.37 | -- | -- |
Interest expense-redeemable preferred stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Interest and other income (expense) | -- | -- | -- | -- | -- | -- | -- | -- | 2.55 | 2.00 |
Foreign exchange gain/(loss) | 4.31 | 4.43 | 3.75 | 4.79 | 2.84 | 5.60 | 2.74 | (0.01) | (4.99) | (2.51) |
Other income, net | 6.77 | 12.07 | 16.51 | 12.99 | 11.36 | 15.14 | 7.03 | 3.97 | -- | -- |
Loss on settlement of convertible notes | (12.85) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Income (loss) before income taxes | 146.56 | 115.33 | 83.10 | 60.37 | 85.03 | 83.88 | 75.78 | 37.64 | 64.98 | 56.72 |
Current- Foreign | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Deferred: Foreign | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Current: Domestic | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Deferred: Domestic | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Income tax provision/(benefit) | 31.85 | 25.63 | 15.17 | 3.40 | 36.15 | 22.15 | 24.21 | 5.19 | 16.88 | 14.88 |
Loss from equity-method investment | 0.05 | (0.23) | (0.27) | (0.25) | -- | -- | -- | -- | -- | -- |
Income from Continuing Operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Income/(loss) from discontinued operations, net of taxes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Consolidated Net Income (Loss) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Dividends and accretion on preferred stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Net Income (Loss) Available to Common Shareholders | 114.76 | 89.48 | 67.66 | 56.73 | 48.89 | 61.73 | 51.57 | 32.45 | 48.10 | 41.84 |
EPS (Basic) : Continuing operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
EPS (Basic) : Discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Net Earnings Per Share (Basic) | 3.42 | 2.61 | 1.97 | 1.65 | 1.44 | 1.84 | 1.55 | 0.99 | 1.47 | 1.31 |
EPS (Diluted) : Continuing operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
EPS (Diluted) : Discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Net Earnings Per Share (Diluted) | 3.35 | 2.59 | 1.95 | 1.62 | 1.39 | 1.79 | 1.51 | 0.96 | 1.42 | 1.26 |
Weighted Average Shares Outstanding (Basic) | 33.55 | 34.27 | 34.35 | 34.45 | 33.90 | 33.57 | 33.30 | 32.81 | 32.75 | 31.97 |
Weighted Average Shares Outstanding (Diluted) | 34.24 | 34.56 | 34.73 | 35.03 | 35.11 | 34.56 | 34.18 | 33.64 | 33.84 | 33.17 |